Your browser doesn't support javascript.
loading
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study.
Harrington, Kevin J; Burtness, Barbara; Greil, Richard; Soulières, Denis; Tahara, Makoto; de Castro, Gilberto; Psyrri, Amanda; Brana, Irene; Basté, Neus; Neupane, Prakash; Bratland, Åse; Fuereder, Thorsten; Hughes, Brett G M; Mesia, Ricard; Ngamphaiboon, Nuttapong; Rordorf, Tamara; Wan Ishak, Wan Zamaniah; Lin, Jianxin; Gumuscu, Burak; Swaby, Ramona F; Rischin, Danny.
Affiliation
  • Harrington KJ; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, National Institute of Health Research Biomedical Research Centre, London, United Kingdom.
  • Burtness B; Yale Cancer Center and Yale School of Medicine, New Haven, CT.
  • Greil R; Salzburg Cancer Research Institute-Center for Clinical Cancer and Immunology Trials, Salzburg, Austria.
  • Soulières D; Paracelsus Medical University Hospital, and Cancer Cluster Salzburg, Salzburg, Austria.
  • Tahara M; Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.
  • de Castro G; National Cancer Center Hospital East, Kashiwa, Japan.
  • Psyrri A; Instituto do Cancer do Estado de Sao Paulo, Sao Paulo, Brazil.
  • Brana I; National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.
  • Basté N; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Neupane P; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Bratland Å; University of Kansas Medical Center, Kansas City, KS.
  • Fuereder T; Oslo University Hospital, Oslo, Norway.
  • Hughes BGM; Medical University of Vienna, Vienna, Austria.
  • Mesia R; Royal Brisbane and Women's Hospital and University of Queensland, Brisbane, QLD, Australia.
  • Ngamphaiboon N; Medical Oncology Department, Catalan Institut of Oncology - Badalona, B-ARGO Group, IGTP, Badalona, Spain.
  • Rordorf T; Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Wan Ishak WZ; University Hospital, Zurich, Switzerland.
  • Lin J; Clinical Oncology Unit, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia.
  • Gumuscu B; Merck & Co, Inc, Rahway, NJ.
  • Swaby RF; Merck & Co, Inc, Rahway, NJ.
  • Rischin D; Merck & Co, Inc, Rahway, NJ.
J Clin Oncol ; 41(4): 790-802, 2023 02 01.
Article in En | MEDLINE | ID: mdl-36219809
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B7-H1 Antigen / Head and Neck Neoplasms Limits: Humans Language: En Journal: J Clin Oncol Year: 2023 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B7-H1 Antigen / Head and Neck Neoplasms Limits: Humans Language: En Journal: J Clin Oncol Year: 2023 Type: Article Affiliation country: United kingdom